文献速递外周动脉疾病

合并糖尿病与外周动脉疾病的医保患者中组织缺损类型与截肢风险的关联

Association between tissue loss type and amputation risk among Medicare patients with concomitant diabetes and peripheral arterial disease.
PubMed 文献 · J Vasc Surg · 2024-06-14

基于2007—2019年医疗保险理赔数据,纳入1225万例合并糖尿病与外周动脉疾病(DM/PAD)患者,按ICD编码划分八类组织缺损。组织缺损者1年截肢率为6.4%,无组织缺损者为0.4%;与无组织缺损者相比,淋巴腺炎者1年截肢风险调整后风险比1.96,坏疽者为28.7。

要点

  • 组织缺损的存在与范围是DM/PAD患者截肢最强的预测因素,效应量大于其他研究因素。
  • 有组织缺损者1年截肢率6.4%,无组织缺损者0.4%。
  • 有组织缺损者1年截肢风险从淋巴腺炎的调整后风险比1.96到坏疽的28.7。

核心结论

  • 在1225万例DM/PAD患者中,截肢最重要的预测因素是组织缺损的存在与范围,其效应量大于所研究的其他任何因素。
  • 任何类型的组织缺损患者需要加速伤口护理、适当时血运重建和感染管理以避免截肢。
  • 在截肢率高的地区建立提供这些干预的照护体系可能对这些人群有益。

研究设计与样本

  • 应用ICD-9和ICD-10编码于2007—2019年医疗保险理赔数据,识别所有持续按服务收费覆盖并诊断为DM/PAD的患者。
  • 使用ICD-9和ICD-10诊断编码建立八类组织缺损,从淋巴腺炎(最轻)到坏疽(最重)。
  • 构建Cox比例风险模型量化组织缺损类型与1年和5年截肢风险的关联,调整年龄、种族/民族、性别、农村性、收入、合并症和预防因素。
  • 在医院转诊区域层面检查DM/PAD率和风险调整截肢率的地区差异。

主要发现

  • 识别12,257,174例DM/PAD患者(48%男性,76%白人,10%既往心肌梗死,30%慢性肾脏病)。
  • 有组织缺损者1年粗截肢率(大截肢和小截肢)为6.4%,无组织缺损者为0.4%。
  • 有组织缺损者中,1年任何截肢率从淋巴腺炎的0.89%到坏疽的26%不等。
  • 与无组织缺损者相比,1年截肢风险从淋巴腺炎的调整后风险比1.96(95%置信区间1.43-2.69)到坏疽的调整后风险比28.7(95%置信区间28.1-29.3)。

临床怎么用

  • 组织缺损可作为识别高危患者的简单标志用于宣传活动。
  • 任何类型的组织缺损患者需要加速伤口护理、适当时血运重建和感染管理以避免截肢。
  • 在截肢率高的地区建立提供这些干预的照护体系可能对这些人群有益。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Prior studies have described risk factors associated with amputation in patients with concomitant diabetes and peripheral arterial disease (DM/PAD). However, the association between the severity and extent of tissue loss type and amputation risk remains less well-described. We aimed to quantify the role of different tissue loss types in amputation risk among patients with DM/PAD, in the context of demographic, preventive, and socioeconomic factors. METHODS: Applying International Classification of Diseases (ICD)-9 and ICD-10 codes to Medicare claims data (2007-2019), we identified all patients with continuous fee-for-service Medicare coverage diagnosed with DM/PAD. Eight tissue loss categories were established using ICD-9 and ICD-10 diagnosis codes, ranging from lymphadenitis (least severe) to gangrene (most severe). We created a Cox proportional hazards model to quantify associations between tissue loss type and 1- and 5-year amputation risk, adjusting for age, race/ethnicity, sex, rurality, income, comorbidities, and preventive factors. Regional variation in DM/PAD rates and risk-adjusted amputation rates was examined at the hospital referral region level. RESULTS: We identified 12,257,174 patients with DM/PAD (48% male, 76% White, 10% prior myocardial infarction, 30% chronic kidney disease). Although 2.2 million patients (18%) had some form of tissue loss, 10.0 million patients (82%) did not. The 1-year crude amputation rate (major and minor) was 6.4% in patients with tissue loss, and 0.4% in patients without tissue loss. Among patients with tissue loss, the 1-year any amputation rate varied from 0.89% for patients with lymphadenitis to 26% for patients with gangrene. The 1-year amputation risk varied from two-fold for patients with lymphadenitis (adjusted hazard ratio, 1.96; 95% confidence interval, 1.43-2.69) to 29-fold for patients with gangrene (adjusted hazard ratio, 28.7; 95% confidence interval, 28.1-29.3), compared with patients without tissue loss. No other demographic variable including age, sex, race, or region incurred a hazard ratio for 1- or 5-year amputation risk higher than the least severe tissue loss category. Results were similar across minor and major amputation, and 1- and 5-year amputation outcomes. At a regional level, higher DM/PAD rates were inversely correlated with risk-adjusted 5-year amputation rates (R2 = 0.43). CONCLUSIONS: Among 12 million patients with DM/PAD, the most significant predictor of amputation was the presence and extent of tissue loss, with an association greater in effect size than any other factor studied. Tissue loss could be used in awareness campaigns as a simple marker of high-risk patients. Patients with any type of tissue loss require expedited wound care, revascularization as appropriate, and infection management to avoid amputation. Establishing systems of care to provide these interventions in regions with high amputation rates may prove beneficial for these populations.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ponukumati AS, Krafcik BM, Newton L, et al. Association between tissue loss type and amputation risk among Medicare patients with concomitant diabetes and peripheral arterial disease. J Vasc Surg. 2024. PMID: 38880181. doi:10.1016/j.jvs.2024.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。